Cormorant Asset Management, LP Erasca, Inc. Transaction History

Cormorant Asset Management, LP

  • $1.74 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$3.89 - $8.57 $1.2 Million - $2.64 Million
307,692 Added 2.93%
10,813,246 $46.6 Million
Q1 2022

May 16, 2022
BUY
$8.6 - $15.48 $34 - $61
4 Added 0.0%
10,505,554 $90.3 Million
Q3 2021

Nov 15, 2021
BUY
$17.43 - $24.34 $183 Million - $256 Million
10,505,550 New
10,505,550 $217 Million

Others Institutions Holding ERAS

# of Institutions
117
Shares Held
74.3M
Call Options Held
7.1K
Put Options Held
40.1K
View Full List

About Erasca, Inc.

ERAS Quotes by TradingView
  • Ticker ERAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,147,000
  • Market Cap $265M
  • Description
  • Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...
More about ERAS
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email